Up to 5.3 million Americans currently have Alzheimer's disease, according to the U.S. Centers for Disease Control and Prevention, a number that is expected to triple by 2050 due to the aging of the population.
Dec 3, 2014
0
0
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.
Sep 15, 2014
0
0
Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug ...
Aug 21, 2014
0
0
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial of CRS3123, an investigational oral antibiotic intended to treat Clostridium ...
Jul 9, 2014
0
0
(Medical Xpress)—A new research study at Northwestern Medicine and Rush University Medical Center is testing whether a new investigational treatment can slow the memory loss caused by Alzheimer's disease.
Jun 25, 2014
0
0
A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types, researchers report. ...
May 31, 2014
0
0
Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found. Their study, published online in the ...
Mar 7, 2014
0
0
Scientists have begun the first human clinical trial of EDP-788, an investigational oral antibiotic intended to treat methicillin-resistant Staphylococcus aureus (MRSA) infections. The Phase 1 trial, which will enroll as ...
Jan 27, 2014
0
0
China's biggest drug distributor says two former executives are the target of a corruption investigation, widening a graft probe that has focused on foreign pharmaceutical makers.
Jan 13, 2014
0
0
Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper from researchers at Memorial Sloan-Kettering Cancer Center published on September 26 in Nature Genetics ...
Sep 27, 2013
0
0
